RxDoctor Payments DataLook up a doctor →

Hamid Bahadori, MD

Neurology · Charleston, SCNPI 1861571887

Payments from drug & device makers

$28,724in general payments, 2019–2025

Across 1,612 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • UCB, Inc.$2K
  • AbbVie$2K
  • SK Life Science, Inc.$2K
  • Acadia Pharmaceuticals Inc$1K
  • Pfizer$1K
  • plus $18K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis150$2,236
UCB, Inc.103$2,080
AbbVie(2 entities)168$1,881
SK Life Science, Inc.76$1,642
Acadia Pharmaceuticals Inc68$1,320
Pfizer62$1,275
EMD Serono, Inc.72$1,274
Teva Pharmaceuticals USA, Inc.96$1,219
Lundbeck LLC43$934
Amgen(2 entities)37$830
Biogen42$789
Lilly USA, LLC39$732
Sanofi34$717
Genentech USA, Inc.42$689
Amneal Pharmaceuticals LLC38$653
Sunovion Pharmaceuticals Inc.58$639
TG Therapeutics, Inc.35$635
AstraZeneca(2 entities)22$552
Bristol Myers Squibb48$550
Argenx US, Inc.19$488
Eisai Inc.23$475
Alnylam Pharmaceuticals Inc.23$443
CSL Behring19$441
MDD US Operations, LLC18$419
Biohaven Pharmaceuticals, Inc.16$339
Biohaven Pharmaceutical Holding Company Ltd.14$324
Johnson & Johnson15$306
Otsuka America Pharmaceutical, Inc.14$287
Octapharma USA, Inc.3$252
Avanir Pharmaceuticals, Inc.13$230
Tanabe Pharma America, Inc.11$206
Kyowa Kirin, Inc.14$204
Upsher-smith Laboratories LLC10$201
Adamas Pharmaceuticals, Inc.12$192
Banner Life Sciences, LLC7$175
Acorda Therapeutics, Inc9$168
ANI Pharmaceuticals, Inc.7$165
Boston Scientific8$161
Takeda Pharmaceuticals U.S.A., Inc.6$160
Grifols USA, LLC8$154
E.r. Squibb & Sons, L.L.C.7$153
Jazz Pharmaceuticals Inc.8$146
Supernus Pharmaceuticals, Inc.8$145
Aquestive Therapeutics, Inc.7$140
Harmony Biosciences LLC5$103
Akcea Therapeutics, Inc.1$95
Hyperfine Operations, Inc.1$94
Bausch Health US, LLC5$94
Hospira, Inc.4$93
Abbott4$90
Axsome Therapeutics, Inc.3$86
GE HealthCare4$84
Impel Pharmaceuticals Inc.4$81
Idorsia Pharmaceuticals US Inc4$73
Merz Pharmaceuticals, LLC3$68
Livanova USA, Inc.3$65
Assertio Therapeutics, Inc.4$63
Vanda Pharmaceuticals Inc.2$55
Sumitomo Pharma America, Inc.4$53
Neurelis, Inc.3$53

How this compares

$28,724 in reported general payments places this provider in the 80th percentile of 270 neurology providers in South Carolina.

See all neurology providers in South Carolina

Medicare billing

Part B allowed, 2024
$202,697
Medicare patients
679
Services billed
1,411

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →